Attention: This platform is in beta mode. Expect some changes and adjustments.

AI Market Mood: Stock Dashboard

ABSI


Fundamental

Company: Absci Corp
Sector: Healthcare
Industry: Biotechnology
Country: USA
Exchange: NASD
Index: RUT
P/E: -
EPS (ttm): -0.90
Insider Own: 9.72%
Shs Outstand: 149.75M
Perf Week: -1.41%
Market Cap: 521.84M
Forward P/E: -
EPS next Y: -0.64
Insider Trans: 1.36%
Shs Float: 135.75M
Perf Month: 14.15%
Enterprise Value: 359.24M
PEG: -
EPS next Q: -0.18
Inst Own: 65.05%
Short Float: 24.33%
Perf Quarter: 10.87%
Income: -114.60M
P/S: 185.71
EPS this Y: 11.97%
Inst Trans: 5.44%
Short Ratio: 6.56
Perf Half Y: 29.01%
Sales: 2.81M
P/B: 2.47
EPS next Y Percentage: 22.26%
ROA: -47.73%
Short Interest: 33.02M
Perf YTD: 32.45%
Book/sh: 1.40
P/C: 3.09
EPS next 5Y: 5.10%
ROE: -55.68%
52W High: 6.33 -45.18%
Perf Year: 25.28%
Cash/sh: 1.12
P/FCF: -
EPS past 3/5Y: 5.67% -29.30%
ROIC: -53.68%
52W Low: 2.01 72.65%
Perf 3Y: 59.92%
Dividend Est.: -
EV/EBITDA: -
Sales past 3/5Y: -1.76% 17.09%
Gross Margin: -331.55%
Volatility W: 3.71%
Volatility M: 7.53%
Perf 5Y: -
Dividend TTM: -
EV/Sales: 127.84
EPS Y/Y TTM: 3.38%
Oper. Margin: -4229.13%
ATR (14): 0.23
Perf 10Y: -
Dividend Ex-Date: -
Quick Ratio: 5.89
Sales Y/Y TTM: -33.09%
Profit Margin: -4071.19%
RSI (14): 49.93
Recom: 1.00
Dividend Gr. 3/5Y: - -
Current Ratio: 5.89
EPS Q/Q: 17.21%
SMA20: -2.07%
Beta: 2.14
Target Price: 8.26
Payout: -
Debt/Eq: 0.03
Sales Q/Q: -77.78%
SMA50: -1.96%
Rel Volume: 0.31
Prev Close: 3.49
Employees: 157
LT Debt/Eq: 0.02
Earnings: Nov 12 AMC
SMA200: 13.07%
Avg Volume: 5.03M
Price: 3.47
IPO: Jul 22, 2021
Option/Short: Yes / Yes
EPS/Sales Surpr.: 2.44% -76.07%
Trades:
Volume: 1,227,372
Change: -0.56%

Technical:


Latest News:

Analysts Have Conflicting Sentiments on These Healthcare Companies: AbSci (ABSI) and ... neutral
ABSI AMGN

Summary: Analysts weigh in on AbSci (ABSI) and Amgen (AMGN) in the Healthcare sector with price targets and ratings provided.

Full article
2024-05-20T15:43:14Z